N-icosanoylsphingosine

Metabolite details

Identifier

XWBWIAOWSABHFI-NUKVNZTCSA-N

InChI Key

XWBWIAOWSABHFI-NUKVNZTCSA-N

IUPAC name

N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide

Preferred name

N-icosanoylsphingosine

INN name

—

Synonym

N-(eicosanoyl)ceramide

ChEBI

CHEBI:72962

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

Observed in differential profiles

• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Baseline_vs_Post-Intervention
• Baseline_vs_Post-Intervention
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Knockdown_vs_Control
• Knockdown_vs_Control
• Mild_vs_Severe